v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Deficit - USD ($)
Common Stock
2024 At the Market Offering Agreement
Common Stock
2026 Equity Purchase Agreement
Common Stock
Lincoln Park Capital Fund
Common Stock
Additional Paid-In Capital
2024 At the Market Offering Agreement
Additional Paid-In Capital
2026 Equity Purchase Agreement
Additional Paid-In Capital
Lincoln Park Capital Fund
Additional Paid-In Capital
Accumulated Deficit
2024 At the Market Offering Agreement
2026 Equity Purchase Agreement
Lincoln Park Capital Fund
Total
Beginning Balance at Dec. 31, 2024       $ 17,000       $ 528,817,000 $ (531,397,000)       $ (2,563,000)
Beginning Balance (in shares) at Dec. 31, 2024       17,407,120                  
Net Income (Loss)                 (1,853,000)       (1,853,000)
Common stock issued during period value new issues $ 12,000       $ 3,325,000         $ 3,337,000      
Common stock issued during period new issues (in shares) 12,277,441                        
Common stock issued for convertible notes settlement       $ 6,000       910,000         916,000
Common stock issued for convertible notes settlement (in shares)       5,465,850                  
Common stock issued for vested restricted stock awards               37,000         37,000
Common stock issued for vested restricted stock awards (in shares)       79,687                  
Stock-based compensation expense               66,000         66,000
Ending Balance at Mar. 31, 2025       $ 35,000       533,155,000 (533,250,000)       (60,000)
Ending Balance (in shares) at Mar. 31, 2025       35,230,098                  
Beginning Balance at Dec. 31, 2024       $ 17,000       528,817,000 (531,397,000)       (2,563,000)
Beginning Balance (in shares) at Dec. 31, 2024       17,407,120                  
Net Income (Loss)                         (4,519,000)
Ending Balance at Jun. 30, 2025       $ 36,000       533,195,000 (535,916,000)       (2,685,000)
Ending Balance (in shares) at Jun. 30, 2025       35,637,325                  
Beginning Balance at Mar. 31, 2025       $ 35,000       533,155,000 (533,250,000)       (60,000)
Beginning Balance (in shares) at Mar. 31, 2025       35,230,098                  
Net Income (Loss)                 (2,666,000)       (2,666,000)
Common stock issued during period value new issues       $ 1,000       24,000         25,000
Common stock issued during period new issues (in shares)       354,988                  
Common stock issued for vested restricted stock awards               45,000         45,000
Common stock issued for vested restricted stock awards (in shares)       52,239                  
Stock-based compensation expense               (29,000)         (29,000)
Ending Balance at Jun. 30, 2025       $ 36,000       533,195,000 (535,916,000)       (2,685,000)
Ending Balance (in shares) at Jun. 30, 2025       35,637,325                  
Beginning Balance at Dec. 31, 2025       $ 43,000       537,202,000 (544,177,000)       (6,932,000)
Beginning Balance (in shares) at Dec. 31, 2025       43,480,411                  
Net Income (Loss)                 676,000       676,000
Common stock issued during period value new issues     $ 1,000       $ 6,000         $ 7,000  
Common stock issued during period new issues (in shares)     20,000                    
Stock-based compensation expense               42,000         42,000
Ending Balance at Mar. 31, 2026       $ 44,000       537,250,000 (543,501,000)       (6,207,000)
Ending Balance (in shares) at Mar. 31, 2026       43,500,411                  
Beginning Balance at Dec. 31, 2025       $ 43,000       537,202,000 (544,177,000)       (6,932,000)
Beginning Balance (in shares) at Dec. 31, 2025       43,480,411                  
Net Income (Loss)                         (1,744,000)
Ending Balance at Jun. 30, 2026       $ 47,000       538,618,000 (545,921,000)       (7,256,000)
Ending Balance (in shares) at Jun. 30, 2026       46,633,744                  
Beginning Balance at Mar. 31, 2026       $ 44,000       537,250,000 (543,501,000)       (6,207,000)
Beginning Balance (in shares) at Mar. 31, 2026       43,500,411                  
Net Income (Loss)                 (2,420,000)       (2,420,000)
Common stock issued during period value new issues   $ 3,000       $ 1,349,000         $ 1,352,000    
Common stock issued during period new issues (in shares)   3,133,333                      
Stock-based compensation expense               19,000         19,000
Ending Balance at Jun. 30, 2026       $ 47,000       $ 538,618,000 $ (545,921,000)       $ (7,256,000)
Ending Balance (in shares) at Jun. 30, 2026       46,633,744